Pharmacological inhibition of GSK3β in organoid models of neurodevelopmental disorders has been shown to rescue cellular disease associated phenotypes [15,16], highlighting the importance of studying the complex roles of GSK3β to understand and treat disorders of brain development. The gene discussed is GSK3B; the disease is neurodevelopmental disorder.